Skip to main content
Clinical Trials/CTRI/2019/05/019222
CTRI/2019/05/019222
Recruiting
Phase 1

A Comparative study comparing intensified treatment with Moxifloxacin/Pyrazinamide versus standard Anti-tubercular therapy for CNS Tuberculoma

Department of Science and Technology0 sites0 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Health Condition 1: A171- Meningeal tuberculoma
Sponsor
Department of Science and Technology
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Clinically and radiologically suspected cases of CNS tuberculoma

Exclusion Criteria

  • \<18yrs, pregnant, HIV positive,refusal to participate in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials